Core Cap Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History
Core Cap Advisors, LLC
- $2.64 Billion
- Q3 2025
A detailed history of Core Cap Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 800 shares of AUPH stock, worth $11,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800
Previous 800
-0.0%
Holding current value
$11,416
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUPH
# of Institutions
255Shares Held
62.5MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$143 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$132 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$56.6 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$39.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$34.2 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.02B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...